Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Takeshi Yoda & Hironobu Katsuyama. (2021) Analysis of antibody-negative medical students after hepatitis B vaccination in Japan. Human Vaccines & Immunotherapeutics 17:3, pages 852-856.
Read now
Read now
Lu Zhang, Wei Wang & Shixia Wang. (2015) Effect of vaccine administration modality on immunogenicity and efficacy. Expert Review of Vaccines 14:11, pages 1509-1523.
Read now
Read now
Hongjing Gu, Tieling Li, Lina Han, Ping Zhu, Peirui Zhang, Shaogeng Zhang, Sujing Sun, Yueqiang Duan, Li Xing, Zhongpeng Zhao, Chengcai Lai, Bohai Wen, Xiliang Wang & PengHui Yang. (2015) Protection conferred by virus-like particle vaccines against respiratory syncytial virus infection in mice by intranasal vaccination . Human Vaccines & Immunotherapeutics 11:4, pages 1057-1064.
Read now
Read now
Satoshi Kashiwagi, Timothy Brauns, Jeffrey Gelfand & Mark C Poznansky. (2014) Laser vaccine adjuvants. Human Vaccines & Immunotherapeutics 10:7, pages 1892-1907.
Read now
Read now
M. Kasım Karahocagil, Turan Buzgan, Hasan Irmak, Hasan Karsen, Hayrettin Akdeniz & Nevzat Akman. (2006) Comparison of Intramuscular and Intradermal Applications of Hepatitis B Vaccine in Hemodialysis Patients. Renal Failure 28:7, pages 561-565.
Read now
Read now
Ulf Carlsson, Lars Brudin, Ingvar Eliasson & Bengt Göran Hansson. (1996) Hepatitis A Vaccination by Intracutaneous Low Dose Administration: A Less Expensive Alternative. Scandinavian Journal of Infectious Diseases 28:5, pages 435-438.
Read now
Read now
Johan Struve. (1992) Hepatitis B Virus Infection Among Swedish Adults: Aspects on Seroepidemiowgy, Transmission, and Vaccine Response. Scandinavian Journal of Infectious Diseases 24:sup82, pages 1-57.
Read now
Read now
Johan Struve, Bo Aronsson, Bertil Frenning, Fredrik Granath, Madeleine Von Sydow & Ola Weiland. (1992) Intramuscular versus Intradermal Administration of a Recombinant Hepatitis B Vaccine: A Comparison of Response Rates and Analysis of Factors Influencing the Antibody Response. Scandinavian Journal of Infectious Diseases 24:4, pages 423-429.
Read now
Read now
Articles from other publishers (43)
Ahmed A.H. Abdellatif, Mahmoud A. Younis, Abdullah F. Alsowinea, Emad M. Abdallah, Mohamed S. Abdel-Bakky, Amal Al-Subaiyel, Yasser A.H. Hassan & Hesham M. Tawfeek. (2023) Lipid nanoparticles technology in vaccines: Shaping the future of prophylactic medicine. Colloids and Surfaces B: Biointerfaces 222, pages 113111.
Crossref
Crossref
Crystal W. Burke, Rebecca A. Erwin-Cohen, Aimee I. Goodson, Catherine Wilhelmsen, Jennifer A. Edmundson, Charles E. White & Pamela J. Glass. (2022) Efficacy of Western, Eastern, and Venezuelan Equine Encephalitis (WEVEE) Virus-Replicon Particle (VRP) Vaccine against WEEV in a Non-Human Primate Animal Model. Viruses 14:7, pages 1502.
Crossref
Crossref
Sakiko Shimizu, Ryo Tanaka, Eriko Itoh, Minami Maekawa-Matsuura & Yoichiro Iwase. (2022) Performance and usability evaluation of novel intradermal injection device Immucise™ and reanalysis of intradermal administration trials of influenza vaccine for the elderly. Vaccine 40:6, pages 873-879.
Crossref
Crossref
Alexander J. Najibi, Ting-Yu Shih & David J. Mooney. (2022) Cryogel vaccines effectively induce immune responses independent of proximity to the draining lymph nodes. Biomaterials 281, pages 121329.
Crossref
Crossref
Roberta Antonia Diotti, Valeria Caputo & Giuseppe Andrea Sautto. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
329
355
.
Charles NdawulaJr.Jr.. (2021) From Bench to Field: A Guide to Formulating and Evaluating Anti-Tick Vaccines Delving beyond Efficacy to Effectiveness. Vaccines 9:10, pages 1185.
Crossref
Crossref
Clare Burn Aschner, Carl Pierce, David M. Knipe & Betsy C. Herold. (2020) Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus. Vaccines 8:2, pages 277.
Crossref
Crossref
Sebastian Ols, Lifei Yang, Elizabeth A. Thompson, Pradeepa Pushparaj, Karen Tran, Frank Liang, Ang Lin, Bengt Eriksson, Gunilla B. Karlsson Hedestam, Richard T. Wyatt & Karin Loré. (2020) Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity. Cell Reports 30:12, pages 3964-3971.e7.
Crossref
Crossref
Masanori Ogawa, Dai Akine & Teppei Sasahara. (2019) Comparison of hepatitis B vaccine efficacy in Japanese students: a retrospective study. Environmental Health and Preventive Medicine 24:1.
Crossref
Crossref
Kei Yamamoto, Mugen Ujiie, Akira Noguchi, Yasuyuki Kato, Yoshihiro Fujiya, Momoko Mawatari, Satoshi Kutsuna, Nozomi Takeshita, Kayoko Hayakawa, Shuzo Kanagawa, Satoshi Inoue, Shigeru Morikawa & Norio Ohmagari. (2019) Rabies post-exposure prophylactic vaccination for returning travelers to Japan. Journal of Infection and Chemotherapy 25:12, pages 931-935.
Crossref
Crossref
B. A. Schaefer, R. A. Gruppo, E. S. Mullins & C. Tarango. (2017) Subcutaneous diphtheria and tetanus vaccines in children with haemophilia: A pilot study and review of the literature. Haemophilia 23:6, pages 904-909.
Crossref
Crossref
Nikolas T. Weissmueller, Leanne Marsay, Heiko A. Schiffter, Robert C. Carlisle, Christine S. Rollier, Robert K. Prud’homme & Andrew J. Pollard. (2017) Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine. PLOS ONE 12:8, pages e0183427.
Crossref
Crossref
Yoshifumi Kimizuka & Satoshi Kashiwagi. (2017) <b>Near-Infrared Laser Vaccine Adjuvant </b>. Nippon Laser Igakkaishi 38:2, pages 69-74.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
696
706
.
Martine A. Boks, Wendy W.J. Unger, Steef Engels, Martino Ambrosini, Yvette van Kooyk & Regina Luttge. (2015) Controlled release of a model vaccine by nanoporous ceramic microneedle arrays. International Journal of Pharmaceutics 491:1-2, pages 375-383.
Crossref
Crossref
Saqib Walayat. (2015) Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World Journal of Hepatology 7:24, pages 2503.
Crossref
Crossref
Xiaoming Chen, Lianyan Wang, Qi Liu, Jilei Jia, Yuan Liu, Weifeng Zhang, Guanghui Ma & Zhiguo Su. (2014) Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes. International Immunopharmacology 23:2, pages 592-602.
Crossref
Crossref
Praveena S. Marconescu, Joan E. Smallshaw, Laurentiu M. Pop, Stephen L. Ruback & Ellen S. Vitetta. (2010) Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxication. Vaccine 28:32, pages 5315-5322.
Crossref
Crossref
Ali Jafer Mohammed, Salah AlAwaidy, Shyam Bawikar, Padmamohan J. Kurup, Emadaldin Elamir, Mahmoud M.A. Shaban, Sharif M. Sharif, Harrie G.A.M. van der Avoort, Mark A. Pallansch, Pradeep Malankar, Anthony Burton, Meghana Sreevatsava & Roland W. Sutter. (2010) Fractional Doses of Inactivated Poliovirus Vaccine in Oman. New England Journal of Medicine 362:25, pages 2351-2359.
Crossref
Crossref
M. STEELE, A. COCHRANE, C. WAKEFIELD, A-M. STAIN, S. LING, V. BLANCHETTE, R. GOLD & L. FORD-JONES. (2009) Hepatitis A and B immunization for individuals with inherited bleeding disorders. Haemophilia 15:2, pages 437-447.
Crossref
Crossref
Laura Sangaré, Lisa Manhart, Darin Zehrung & Chia C. Wang. (2009) Intradermal hepatitis B vaccination: A systematic review and meta-analysis. Vaccine 27:12, pages 1777-1786.
Crossref
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions
1600
1609
.
William L Irving & Kit Harling. 2005. Viral Hepatitis. Viral Hepatitis
693
713
.
Edward Rothstein, Katrin S Kohl, Leslie Ball, Scott A Halperin, Neal Halsey, Sandra Jo Hammer, Paul T Heath, Renald Hennig, Cynthia Kleppinger, Jerry Labadie, Frederick Varricchio, Patricia Vermeer & Wikke Walop. (2004) Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 22:5-6, pages 575-585.
Crossref
Crossref
Elizabeth A. Henderson, Thomas J. Louie, Karam Ramotar, Donna Ledgerwood, Karen Myrthu Hope & Agnes Kennedy. (2015) Comparison of Higher-Dose Intradermal Hepatitis B Vaccination to Standard Intramuscular Vaccination of Healthcare Workers. Infection Control & Hospital Epidemiology 21:4, pages 264-269.
Crossref
Crossref
Ayten Egemen, Sadik Aksit, Zafer Kurugöl, Selda Erensoy, Altinay Bilgiç & Münevver Akilli. (1998) Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine: a comparison of immunogenicity in infants and preschool children. Vaccine 16:16, pages 1511-1515.
Crossref
Crossref
Marília Dalva TURCHI, Celina Maria Turchi MARTELLI, Maria Lúcia FERRAZ, Antonio Eduardo SILVA, Divina das Dores de Paula CARDOSO, Pierpaolo MARTELLI & Lilian Joy W. Antunes OLIVEIRA. (1997) IMMUNOGENICITY OF LOW-DOSE INTRAMUSCULAR AND INTRADERMAL VACCINATION WITH RECOMBINANT HEPATITIS B VACCINE. Revista do Instituto de Medicina Tropical de São Paulo 39:1, pages 15-20.
Crossref
Crossref
Mizuho Tamura, Yung Choon Yoo, Kumiko Yoshimatsu, Ryu Yoshida, Tetsuya Oka, Kunio Ohkuma, Jiro Arikawa & Ichiro Azuma. (1995) Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen. Vaccine 13:1, pages 77-82.
Crossref
Crossref
Jacqueline S. Coberly, Timothy Townsend, John Repke, Howard Fields, Harold Margolis & Neal A. Halsey. (1994) Suboptimal response following intradermal hepatitis B vaccine in infants. Vaccine 12:11, pages 984-987.
Crossref
Crossref
Sandra C Thompson, Raelene Darlington, Diane Tallent & Jocelyn R L Forsyth. (1993) Booster doses of hepatitis B vaccine: responses to low‐dose inoculations. Medical Journal of Australia 158:6, pages 375-378.
Crossref
Crossref
Sandra C Thompson, Raelene Darlington, Diane Tallent, Jocelyn R L Forsyth & Roy Robins‐Browne. (1993) Effectiveness of low‐dose intradermal hepatitis B vaccination: Five years’ experience of primary vaccination. Medical Journal of Australia 158:6, pages 372-375.
Crossref
Crossref
Alan R. Hinman, Walter A. Orenstein & Edward A. MortimerJr.Jr.. (1992) When, where, and how do immunizations fail?. Annals of Epidemiology 2:6, pages 805-812.
Crossref
Crossref
Joe P. Bryan, Maria H. Sjogren, Philip Macarthy, Elizabeth Cox, Llewellyn J. Legters & Peter L. Perine. (1992) Persistence of antibody to hepatitis B surface antigen after low-dose, intradermal hepatitis B immunization and response to a booster dose. Vaccine 10:1, pages 33-38.
Crossref
Crossref
G. Söyletir, E. Bahçeci, E. Akoğlu, U. Soyoğul & R.A. Lawrance. (1992) Clinical evaluation of low dose intradermally administered hepatitis B vaccine: a comparison of plasma-derived and recombinant yeast-derived vaccines. Vaccine 10:5, pages 301-304.
Crossref
Crossref
Patrick J. Coleman, Frederic E. ShawJrJr, Jan Serovich, Stephen C. Hadler & Harold S. Margolis. (1991) Intradermal hepatitis B vaccination in a large hospital employee population. Vaccine 9:10, pages 723-727.
Crossref
Crossref
Michael P. Rivey & John Peterson. (2016) Intradermal Hepatitis B Vaccination. DICP 25:6, pages 628-634.
Crossref
Crossref
W. Paul McKinney, Susan K. Russler, Mary M. Horowitz, Richard J. Battiola & Martha Bi-Fong Lee. (2016) Duration of Response to Intramuscular Versus Low Dose Intradermal Hepatitis B Booster Immunization. Infection Control & Hospital Epidemiology 12:4, pages 226-230.
Crossref
Crossref
W. Paul McKinney, Susan K. Russler, Mary M. Horowitz, Richard J. Battiola & Martha Bi-Fong Lee. (2017) Duration of Response to Intramuscular Versus Low Dose Intradermal Hepatitis B Booster Immunization. Infection Control & Hospital Epidemiology 12:4, pages 226-230.
Crossref
Crossref
Lynette L. E. Oon, Alistair King, Julie A. Higgins, Christine A. Lee, Peter B. A. Kernoff & Alison H. Goodall. (1991) Protective antibodies to hepatitis B virus in haemophiliacs. Journal of Medical Virology 33:1, pages 19-25.
Crossref
Crossref
M.L. González, M. Usandizaga, P. Alomar, F. Salvá, F. Martín, M.J. Erroz & R. Lardinois. (1990) Intradermal and intramuscular route for vaccination against hepatitis B. Vaccine 8:4, pages 402-405.
Crossref
Crossref
C M McKee, P Duke, M B McEvoy & M C Kelsey. (2016) Effectiveness of Intradermal Hepatitis B Immunization of Hospital Staff. International Journal of STD & AIDS 1:1, pages 32-34.
Crossref
Crossref
F. Blaine Hollinger. (1989) Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. The American Journal of Medicine 87:3, pages S36-S40.
Crossref
Crossref
S. Dittmann. 1989.
271
294
.